PERSPECTIVE THERAPEUTICS, INC. Goodwill, Acquired During Period
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Goodwill, Acquired During Period of $24.06 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-03-28
- PERSPECTIVE THERAPEUTICS, INC. goodwill, acquired during period for the quarter ending 2023-12-31 was -$3.26M.
- PERSPECTIVE THERAPEUTICS, INC. goodwill, acquired during period for the quarter ending 2023-09-30 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. goodwill, acquired during period for fiscal 2023 was $24.06M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$3.26M derived: sum of 2 quarters · filed 2024-03-28 | $24.06M 10-K · filed 2024-03-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $27.32M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $27.32M 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |